ReproNovo ApS
Private limited companyCVR 44291908København SActive
ReproNovo ApS is a private limited company, based in København S, active in manufacture of pharmaceutical preparations, founded in 2023. Net profit rose 25% from 2024 to 2025, ending at DKK 1.5m. Equity grew to DKK 2.8m in 2025. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 28% (2024 → 2025), to DKK 18.9m.
- Net profit rose 25% (2024 → 2025), to DKK 1.5m.
- Equity rose 121% (2024 → 2025), to DKK 2.8m.
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2024–2025 · amounts in DKK thousandEquity and net profit
| 2024 | 2025 | Change | |
|---|---|---|---|
| Revenue | 32,401 | not stated | – |
| Gross profit | 14,801 | 18,904 | +27.7% |
| Operating profit (EBIT) | 1,721 | 2,701 | +56.9% |
| Profit before tax | 1,543 | 1,977 | +28.2% |
| Net profit | 1,214 | 1,524 | +25.5% |
| Total assets | 6,008 | 17,315 | +188.2% |
| Equity | 1,254 | 2,778 | +121.5% |
| Liabilities | 4,754 | 14,537 | +205.8% |
| Cash and cash equivalents | 3,828 | 6,286 | +64.2% |
| Average number of employees | 10 | 10 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
2 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 01/07/2026 | The company | PDF not statedXBRL |
| 2024 | 07/09/2023 – 31/12/2024 | 02/07/2025 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
59 companies in the databaseComparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.
Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 1,660of 69,742 Better than 98% | No. 20,252of 69,964 Better than 71% |
| Same industry and fewer than 20 employees37 companies in the comparison | No. 6of 36 Better than 86% | No. 18of 37 Better than 53% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 449of 16,614 Better than 97% | No. 1,975of 16,661 Better than 88% |
| All companies of type ApS66,508 companies in the comparison | No. 2,634of 66,379 Better than 96% | No. 16,694of 66,505 Better than 75% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of pharmaceutical preparations- ReproNovo ApSDKK 18.9m
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- ReproNovo ApSDKK 1.5m
- Novo Nordisk A/SDKK 102.4bn
- H. Lundbeck A/SDKK 3.2bn
- ReproNovo ApSDKK 2.8m
- Novo Nordisk A/SDKK 194bn
- H. Lundbeck A/SDKK 24.9bn
- ReproNovo ApS10
- Novo Nordisk A/S27,279
- H. Lundbeck A/S2,261
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- ReproNovo SA100%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Joan Carles Arce Saez | Director | 07/09/2023 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Joan Carles Arce Saez | Board member | 07/09/2023 |
| Jean Marie Duvall | Board member | 07/09/2023 |
| BingMei Hao | Chair of the board | 07/09/2023 |
- Auditor
- Ecovis Danmark statsautoriseret revisionsinteressentskab
- Founders
- ReproNovo SA
Signing rule: Selskabet tegnes af formanden for bestyrelsen i forening med en direktør, eller af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Address and production units
1 active production unitsAmagerfælledvej 106
2300 København S
København Municipality · Postcode 2300
Other companies at the address (8)
- ZeroNorth A/SOther software publishing
- Mono Solutions ApSComputer programming activities
- Ardoq Denmark ApSOther software publishing
- Source2Sea A/SNon-specialised wholesale trade
- Nu Skin Scandinavia A/SWholesale of perfume and cosmetics
| Production unit | Address | Employees | P number |
|---|---|---|---|
| ReproNovo ApS | Amagerfælledvej 106, 2300 København S | 11 | 1029624557 |
Purpose
Selskabets formål er at forske, udvikle og markedsføre terapeutiske løsninger til behandling af sygdomme samt al virksomhed, som efter bestyrelsens skøn har forbindelse hermed.
The purpose is quoted from the register in Danish.
Changes year by year
9 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20251 changeaccounts 1
- AccountsAnnual report for 2024 published
20237 changesaddress 1 · founded 1 · management 4 · ownership 1
- AddressMoved to Amagerfælledvej 106, 2300 København S
- FoundedRegistered as ReproNovo ApS
- ManagementJoan Carles Arce Saez appointed director
- ManagementJoan Carles Arce Saez appointed board member
- ManagementJean Marie Duvall appointed board member
- ManagementBingMei Hao appointed chair of the board
- OwnershipReproNovo SA registered as owner (100%)
Related companies
Same industry in København
- H. Lundbeck A/S2,261 employees
- AJ Vaccines A/S499 employees
- Tetra Pharm Technologies ApS39 employees
- Motilitycount ApS29 employees
- Freya Biosciences ApS18 employees
- Zerion Pharma A/S15 employees
Largest in the industry
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Leo Pharma A/SDKK 8.2bn
- Alk-abelló A/SDKK 4.2bn
- Bavarian Nordic A/SDKK 3bn
- Pharmacosmos A/SDKK 1.6bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.